These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30417801)

  • 41. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
    Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
    Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regional atrophy is associated with impairment in distinct cognitive domains in Alzheimer's disease.
    Smits LL; Tijms BM; Benedictus MR; Koedam EL; Koene T; Reuling IE; Barkhof F; Scheltens P; Pijnenburg YA; Wattjes MP; van der Flier WM
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S299-305. PubMed ID: 24210526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A specific pattern of gray matter atrophy in Alzheimer's disease with depression.
    Karavasilis E; Parthimos TP; Papatriantafyllou JD; Papageorgiou SG; Kapsas G; Papanicolaou AC; Seimenis I
    J Neurol; 2017 Oct; 264(10):2101-2109. PubMed ID: 28856425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer's disease.
    Lee LH; Wu SC; Ho CF; Liang WL; Liu YC; Chou CJ
    PLoS One; 2023; 18(3):e0283790. PubMed ID: 37000849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment.
    Falgàs N; Balasa M; Bargalló N; Borrego-Écija S; Ramos-Campoy O; Fernández-Villullas G; Bosch B; Olives J; Tort-Merino A; Antonell A; Castellví M; Allen IE; Sánchez-Valle R; Lladó A
    J Alzheimers Dis; 2020; 73(4):1575-1583. PubMed ID: 31958089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients.
    Logue MW; Posner H; Green RC; Moline M; Cupples LA; Lunetta KL; Zou H; Hurt SW; Farrer LA; Decarli C;
    Alzheimers Dement; 2011 Sep; 7(5):493-500. PubMed ID: 21723205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study.
    van der Flier WM; van Straaten EC; Barkhof F; Ferro JM; Pantoni L; Basile AM; Inzitari D; Erkinjuntti T; Wahlund LO; Rostrup E; Schmidt R; Fazekas F; Scheltens P;
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1497-500. PubMed ID: 16227537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combining visual rating scales to identify prodromal Alzheimer's disease and Alzheimer's disease dementia in a population from a low and middle-income country.
    Custodio N; Malaga M; Chambergo-Michilot D; Montesinos R; Moron E; Vences MA; Huilca JC; Lira D; Failoc-Rojas VE; Diaz MM
    Front Neurol; 2022; 13():962192. PubMed ID: 36119675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
    Scheltens P; Leys D; Barkhof F; Huglo D; Weinstein HC; Vermersch P; Kuiper M; Steinling M; Wolters EC; Valk J
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):967-72. PubMed ID: 1431963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Observational Study of Clinical and Functional Progression Based on Initial Brain MRI Characteristics in Patients with Alzheimer's Disease.
    Choi H; Yang Y; Han HJ; Jeong JH; Park MY; Kim YB; Jo KD; Choi JY; Kang KH; Kang H; Kwon DY; Yoo BG; Lee HJ; Shin BS; Jeon SM; Kwon OD; Kim JS; Lee SJ; Kim Y; Park TH; Kim YJ; Yang HJ; Park HY; Shin HE; Lee JS; Jung YH; Lee AY; Shin DI; Shin KJ; Park KH
    J Alzheimers Dis; 2018; 66(4):1721-1730. PubMed ID: 30452413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Relationship Between Medial Temporal Lobe Atrophy and Cognitive Impairment in Patients With Dementia With Lewy Bodies.
    Tagawa R; Hashimoto H; Nakanishi A; Kawarada Y; Muramatsu T; Matsuda Y; Kataoka K; Shimada A; Uchida K; Yoshida A; Higashiyama S; Kawabe J; Kai T; Shiomi S; Mori H; Inoue K
    J Geriatr Psychiatry Neurol; 2015 Dec; 28(4):249-54. PubMed ID: 26071442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment.
    Caroli A; Testa C; Geroldi C; Nobili F; Guerra UP; Bonetti M; Frisoni GB
    J Neurol; 2007 Aug; 254(8):1000-8. PubMed ID: 17375260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.
    Carmichael O; Schwarz C; Drucker D; Fletcher E; Harvey D; Beckett L; Jack CR; Weiner M; DeCarli C;
    Arch Neurol; 2010 Nov; 67(11):1370-8. PubMed ID: 21060014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia.
    van Straaten EC; Harvey D; Scheltens P; Barkhof F; Petersen RC; Thal LJ; Jack CR; DeCarli C;
    J Neurol; 2008 Sep; 255(9):1302-8. PubMed ID: 18825439
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study.
    Kim S; Choi SH; Lee YM; Kim MJ; Kim YD; Kim JY; Park JH; Myung W; Na HR; Han HJ; Shim YS; Kim JH; Yoon SJ; Kim SY; Kim DK
    Int Psychogeriatr; 2015 Dec; 27(12):2069-77. PubMed ID: 26212042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population.
    Claus JJ; Staekenborg SS; Holl DC; Roorda JJ; Schuur J; Koster P; Tielkes CEM; Scheltens P
    Eur Radiol; 2017 Aug; 27(8):3147-3155. PubMed ID: 28083697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    Tai H; Hirano S; Sakurai T; Nakano Y; Ishikawa A; Kojima K; Li H; Shimada H; Kashiwado K; Mukai H; Horikoshi T; Sugiyama A; Uno T; Kuwabara S
    J Alzheimers Dis; 2020; 78(4):1639-1652. PubMed ID: 33185599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiating MCI from depression through verbal memory scores.
    Cankaya S; Yalciner B; Yilmaz MK; Yulug B
    Alzheimers Dement (N Y); 2024; 10(1):e12448. PubMed ID: 38356476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.